P3 Health Partners Inc (PIII)

Currency in USD
11.3700
+7.3400(+182.13%)
Real-time Data·
Unusual trading volume
Trading near 52-week High
PIII is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.051814.3500
52 wk Range
1.520014.3500
Key Statistics
Prev. Close
4.03
Open
5.28
Day's Range
5.0518-14.35
52 wk Range
1.52-14.35
Volume
53.86M
Average Volume (3m)
55.72K
1-Year Change
37.1133%
Book Value / Share
-47.23
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PIII Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.5000
Downside
-69.22%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

P3 Health Partners Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 3.5000
(-69.22% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Lake Street
Buy14.00+21.14%4.00MaintainMay 15, 2026
TD Cowen
Hold3.00-74.04%8.00MaintainApr 02, 2026
Lake Street
Buy4.00-65.39%12.50MaintainMar 27, 2026
Lake Street Capital Markets
Buy12.50+8.17%20.00MaintainNov 17, 2025
Lake Street Capital Markets
Buy20.00+73.06%-New CoverageAug 28, 2025

P3 Health Partners Inc Earnings Call Summary for Q1/2026

  • Q1 2026 revenue rose 3.5% YoY to $386M; adjusted EBITDA swung to $26M profit from $22M loss in Q1 2025, marking financial inflection point.
  • Two-year strategic restructuring improved payer contracts and operations; medical loss ratio reached 85.2% with $74M medical margin.
  • Full-year 2026 adjusted EBITDA guidance raised to $20M-$60M range (midpoint $40M), reflecting confidence in structural improvements.
  • Stock surged 12.89% to $3.57 post-earnings despite 48% six-month decline; CEO Coffman cited strong setup for remainder of 2026.
  • Deliberate membership reduction poses revenue growth risk; company focuses on expanding medical margins and managing costs amid EPS loss forecasts.
Last Updated: 14/05/2026, 22:10
Read Full Transcript

Earnings

Latest Release
Mar 26, 2026
EPS / Forecast
-23.02 / -0.10
Revenue / Forecast
384.81M / 357.13M
EPS Revisions
Last 90 days

PIII Income Statement

Compare PIII to Peers and Sector

Metrics to compare
PIII
Peers
Sector
Relationship
P/E Ratio
−0.2x−11.4x−0.5x
PEG Ratio
0.00−0.070.00
Price/Book
−0.2x5.1x2.6x
Price / LTM Sales
0.0x1.0x3.2x
Upside (Analyst Target)
23.7%31.8%50.4%
Fair Value Upside
Unlock−0.2%7.2%Unlock

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
96.32K2.92%343.85K
Other Institutional Investors
2.23M67.64%7.96M
Public Companies & Retail Investors
969.67K29.43%3.46M
Total
3.29M100.00%11.76M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Chicago Pacific Founders42.71%1,406,8855,670
Leavitt Equity Partners10.81%356,2701,436

People Also Watch

95.31
MXL
+7.36%
127.31
FORM
-0.53%
155.87
ATI
-4.12%
2.125
VNRX
-3.41%
0.297
NOTV
-3.98%

FAQ

What Is the P3 Health Partners (PIII) Stock Price Today?

The P3 Health Partners stock price today is 11.3700 USD.

What Stock Exchange Does P3 Health Partners Trade On?

P3 Health Partners is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for P3 Health Partners?

The stock symbol for P3 Health Partners is "PIII."

What Is the P3 Health Partners (PIII) Afterhours Price Today? (Afterhours variable test: 5.7500) Current Date: May 15, 2026

After hours price: 5.7500. After hours price change (units): 1.7200. Price change percentage: 42.6800%

What Is the P3 Health Partners Market Cap?

As of today, P3 Health Partners market cap is 82.4000M USD.

What Is P3 Health Partners's Earnings Per Share (TTM)?

The P3 Health Partners EPS (TTM) is -45.2600.

From a Technical Analysis Perspective, Is PIII a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has P3 Health Partners Stock Split?

P3 Health Partners has split 1 times.

How Many Employees Does P3 Health Partners Have?

P3 Health Partners has 320 employees.

What is the current trading status of P3 Health Partners (PIII)?

As of May 15, 2026, P3 Health Partners (PIII) is trading at a price of 11.3700 USD, with a previous close of 4.0300 USD. The stock has fluctuated within a day range of 5.0518 USD to 14.3500 USD, while its 52-week range spans from 1.5200 USD to 14.3500 USD.

What Is P3 Health Partners (PIII) Price Target According to Analysts?

The average 12-month price target for P3 Health Partners is 3.5000 USD, with a high estimate of 4 USD and a low estimate of 3 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an -69.22% Downside potential.

What Is the PIII Premarket Price?

PIII's last pre-market stock price is 5.2700 USD. The pre-market share volume is 503,180.0000, and the stock has decreased by 1.2400, or 30.7700%.

What Is the PIII After Hours Price?

PIII's last after hours stock price is 5.7500 USD, the stock has decreased by 1.7200, or 42.6800%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.